 | • レポートコード：GIR-107A12597 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、帯状疱疹後神経痛治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。帯状疱疹後神経痛治療の種類別市場規模（医薬品、パッチ、ステロイド注射剤）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・帯状疱疹後神経痛治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Endo Pharmaceuticals、Depomed、Acorda Therapeutics、Pfizer、Mylan、Daiichi Sankyo、Teikoku Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：医薬品、パッチ、ステロイド注射剤 ・用途別分析2016年-2026年：病院薬局、オンライン薬局、小売薬局 ・帯状疱疹後神経痛治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・帯状疱疹後神経痛治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・帯状疱疹後神経痛治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・帯状疱疹後神経痛治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・帯状疱疹後神経痛治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Post Herpetic Neuralgia Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Post Herpetic Neuralgia Therapies size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Post Herpetic Neuralgia Therapies market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Post Herpetic Neuralgia Therapies market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Drugs
Patches
Steroid Injectable
Market segment by Application, can be divided into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Market segment by players, this report covers
Endo Pharmaceuticals
Depomed
Acorda Therapeutics
Pfizer
Mylan
Daiichi Sankyo
Teikoku Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Post Herpetic Neuralgia Therapies
1.2 Classification of Post Herpetic Neuralgia Therapies by Type
1.2.1 Overview: Global Post Herpetic Neuralgia Therapies Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Post Herpetic Neuralgia Therapies Revenue Market Share by Type in 2020
1.2.3 Drugs
1.2.4 Patches
1.2.5 Steroid Injectable
1.3 Global Post Herpetic Neuralgia Therapies Market by Application
1.3.1 Overview: Global Post Herpetic Neuralgia Therapies Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Post Herpetic Neuralgia Therapies Market Size & Forecast
1.5 Global Post Herpetic Neuralgia Therapies Market Size and Forecast by Region
1.5.1 Global Post Herpetic Neuralgia Therapies Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Post Herpetic Neuralgia Therapies Market Size by Region, (2016-2021)
1.5.3 North America Post Herpetic Neuralgia Therapies Market Size and Prospect (2016-2026)
1.5.4 Europe Post Herpetic Neuralgia Therapies Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Post Herpetic Neuralgia Therapies Market Size and Prospect (2016-2026)
1.5.6 South America Post Herpetic Neuralgia Therapies Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Post Herpetic Neuralgia Therapies Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Post Herpetic Neuralgia Therapies Market Drivers
1.6.2 Post Herpetic Neuralgia Therapies Market Restraints
1.6.3 Post Herpetic Neuralgia Therapies Trends Analysis
2 Company Profiles
2.1 Endo Pharmaceuticals
2.1.1 Endo Pharmaceuticals Details
2.1.2 Endo Pharmaceuticals Major Business
2.1.3 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Product and Solutions
2.1.4 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Endo Pharmaceuticals Recent Developments and Future Plans
2.2 Depomed
2.2.1 Depomed Details
2.2.2 Depomed Major Business
2.2.3 Depomed Post Herpetic Neuralgia Therapies Product and Solutions
2.2.4 Depomed Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Depomed Recent Developments and Future Plans
2.3 Acorda Therapeutics
2.3.1 Acorda Therapeutics Details
2.3.2 Acorda Therapeutics Major Business
2.3.3 Acorda Therapeutics Post Herpetic Neuralgia Therapies Product and Solutions
2.3.4 Acorda Therapeutics Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Acorda Therapeutics Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Post Herpetic Neuralgia Therapies Product and Solutions
2.4.4 Pfizer Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Post Herpetic Neuralgia Therapies Product and Solutions
2.5.4 Mylan Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Mylan Recent Developments and Future Plans
2.6 Daiichi Sankyo
2.6.1 Daiichi Sankyo Details
2.6.2 Daiichi Sankyo Major Business
2.6.3 Daiichi Sankyo Post Herpetic Neuralgia Therapies Product and Solutions
2.6.4 Daiichi Sankyo Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Daiichi Sankyo Recent Developments and Future Plans
2.7 Teikoku Pharma
2.7.1 Teikoku Pharma Details
2.7.2 Teikoku Pharma Major Business
2.7.3 Teikoku Pharma Post Herpetic Neuralgia Therapies Product and Solutions
2.7.4 Teikoku Pharma Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Teikoku Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Post Herpetic Neuralgia Therapies Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Post Herpetic Neuralgia Therapies Players Market Share
3.2.2 Top 10 Post Herpetic Neuralgia Therapies Players Market Share
3.2.3 Market Competition Trend
3.3 Post Herpetic Neuralgia Therapies Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Post Herpetic Neuralgia Therapies Revenue and Market Share by Type (2016-2021)
4.2 Global Post Herpetic Neuralgia Therapies Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Post Herpetic Neuralgia Therapies Revenue Market Share by Application (2016-2021)
5.2 Post Herpetic Neuralgia Therapies Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Post Herpetic Neuralgia Therapies Revenue by Type (2016-2026)
6.2 North America Post Herpetic Neuralgia Therapies Revenue by Application (2016-2026)
6.3 North America Post Herpetic Neuralgia Therapies Market Size by Country
6.3.1 North America Post Herpetic Neuralgia Therapies Revenue by Country (2016-2026)
6.3.2 United States Post Herpetic Neuralgia Therapies Market Size and Forecast (2016-2026)
6.3.3 Canada Post Herpetic Neuralgia Therapies Market Size and Forecast (2016-2026)
6.3.4 Mexico Post Herpetic Neuralgia Therapies Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Post Herpetic Neuralgia Therapies Revenue by Type (2016-2026)
7.2 Europe Post Herpetic Neuralgia Therapies Revenue by Application (2016-2026)
7.3 Europe Post Herpetic Neuralgia Therapies Market Size by Country
7.3.1 Europe Post Herpetic Neuralgia Therapies Revenue by Country (2016-2026)
7.3.2 Germany Post Herpetic Neuralgia Therapies Market Size and Forecast (2016-2026)
7.3.3 France Post Herpetic Neuralgia Therapies Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Post Herpetic Neuralgia Therapies Market Size and Forecast (2016-2026)
7.3.5 Russia Post Herpetic Neuralgia Therapies Market Size and Forecast (2016-2026)
7.3.6 Italy Post Herpetic Neuralgia Therapies Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Post Herpetic Neuralgia Therapies Revenue by Type (2016-2026)
8.2 Asia-Pacific Post Herpetic Neuralgia Therapies Revenue by Application (2016-2026)
8.3 Asia-Pacific Post Herpetic Neuralgia Therapies Market Size by Region
8.3.1 Asia-Pacific Post Herpetic Neuralgia Therapies Revenue by Region (2016-2026)
8.3.2 China Post Herpetic Neuralgia Therapies Market Size and Forecast (2016-2026)
8.3.3 Japan Post Herpetic Neuralgia Therapies Market Size and Forecast (2016-2026)
8.3.4 South Korea Post Herpetic Neuralgia Therapies Market Size and Forecast (2016-2026)
8.3.5 India Post Herpetic Neuralgia Therapies Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Post Herpetic Neuralgia Therapies Market Size and Forecast (2016-2026)
8.3.7 Australia Post Herpetic Neuralgia Therapies Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Post Herpetic Neuralgia Therapies Revenue by Type (2016-2026)
9.2 South America Post Herpetic Neuralgia Therapies Revenue by Application (2016-2026)
9.3 South America Post Herpetic Neuralgia Therapies Market Size by Country
9.3.1 South America Post Herpetic Neuralgia Therapies Revenue by Country (2016-2026)
9.3.2 Brazil Post Herpetic Neuralgia Therapies Market Size and Forecast (2016-2026)
9.3.3 Argentina Post Herpetic Neuralgia Therapies Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Post Herpetic Neuralgia Therapies Revenue by Type (2016-2026)
10.2 Middle East & Africa Post Herpetic Neuralgia Therapies Revenue by Application (2016-2026)
10.3 Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Country
10.3.1 Middle East & Africa Post Herpetic Neuralgia Therapies Revenue by Country (2016-2026)
10.3.2 Turkey Post Herpetic Neuralgia Therapies Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Post Herpetic Neuralgia Therapies Market Size and Forecast (2016-2026)
10.3.4 UAE Post Herpetic Neuralgia Therapies Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Post Herpetic Neuralgia Therapies Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Post Herpetic Neuralgia Therapies Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Post Herpetic Neuralgia Therapies Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Post Herpetic Neuralgia Therapies Revenue (USD Million) by Region (2016-2021)
Table 5. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Region (2021-2026)
Table 6. Endo Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 7. Endo Pharmaceuticals Major Business
Table 8. Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Product and Solutions
Table 9. Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Depomed Corporate Information, Head Office, and Major Competitors
Table 11. Depomed Major Business
Table 12. Depomed Post Herpetic Neuralgia Therapies Product and Solutions
Table 13. Depomed Post Herpetic Neuralgia Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Acorda Therapeutics Corporate Information, Head Office, and Major Competitors
Table 15. Acorda Therapeutics Major Business
Table 16. Acorda Therapeutics Post Herpetic Neuralgia Therapies Product and Solutions
Table 17. Acorda Therapeutics Post Herpetic Neuralgia Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Pfizer Corporate Information, Head Office, and Major Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Post Herpetic Neuralgia Therapies Product and Solutions
Table 21. Pfizer Post Herpetic Neuralgia Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Mylan Corporate Information, Head Office, and Major Competitors
Table 23. Mylan Major Business
Table 24. Mylan Post Herpetic Neuralgia Therapies Product and Solutions
Table 25. Mylan Post Herpetic Neuralgia Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Daiichi Sankyo Corporate Information, Head Office, and Major Competitors
Table 27. Daiichi Sankyo Major Business
Table 28. Daiichi Sankyo Post Herpetic Neuralgia Therapies Product and Solutions
Table 29. Daiichi Sankyo Post Herpetic Neuralgia Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Teikoku Pharma Corporate Information, Head Office, and Major Competitors
Table 31. Teikoku Pharma Major Business
Table 32. Teikoku Pharma Post Herpetic Neuralgia Therapies Product and Solutions
Table 33. Teikoku Pharma Post Herpetic Neuralgia Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Post Herpetic Neuralgia Therapies Revenue (USD Million) by Players (2019-2021)
Table 35. Global Post Herpetic Neuralgia Therapies Revenue Share by Players (2019-2021)
Table 36. Breakdown of Post Herpetic Neuralgia Therapies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Post Herpetic Neuralgia Therapies Players Head Office, Products and Services Provided
Table 38. Post Herpetic Neuralgia Therapies Mergers & Acquisitions in the Past Five Years
Table 39. Post Herpetic Neuralgia Therapies New Entrants and Expansion Plans
Table 40. Global Post Herpetic Neuralgia Therapies Revenue (USD Million) by Type (2016-2021)
Table 41. Global Post Herpetic Neuralgia Therapies Revenue Share by Type (2016-2021)
Table 42. Global Post Herpetic Neuralgia Therapies Revenue Forecast by Type (2021-2026)
Table 43. Global Post Herpetic Neuralgia Therapies Revenue by Application (2016-2021)
Table 44. Global Post Herpetic Neuralgia Therapies Revenue Forecast by Application (2021-2026)
Table 45. North America Post Herpetic Neuralgia Therapies Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Post Herpetic Neuralgia Therapies Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Post Herpetic Neuralgia Therapies Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Post Herpetic Neuralgia Therapies Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Post Herpetic Neuralgia Therapies Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Post Herpetic Neuralgia Therapies Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Post Herpetic Neuralgia Therapies Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Post Herpetic Neuralgia Therapies Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Post Herpetic Neuralgia Therapies Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Post Herpetic Neuralgia Therapies Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Post Herpetic Neuralgia Therapies Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Post Herpetic Neuralgia Therapies Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Post Herpetic Neuralgia Therapies Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Post Herpetic Neuralgia Therapies Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Post Herpetic Neuralgia Therapies Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Post Herpetic Neuralgia Therapies Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Post Herpetic Neuralgia Therapies Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Post Herpetic Neuralgia Therapies Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Post Herpetic Neuralgia Therapies Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Post Herpetic Neuralgia Therapies Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Post Herpetic Neuralgia Therapies Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Post Herpetic Neuralgia Therapies Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Post Herpetic Neuralgia Therapies Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Post Herpetic Neuralgia Therapies Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Post Herpetic Neuralgia Therapies Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Post Herpetic Neuralgia Therapies Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Post Herpetic Neuralgia Therapies Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Post Herpetic Neuralgia Therapies Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Post Herpetic Neuralgia Therapies Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Post Herpetic Neuralgia Therapies Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Post Herpetic Neuralgia Therapies Picture
Figure 2. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Type in 2020
Figure 3. Drugs
Figure 4. Patches
Figure 5. Steroid Injectable
Figure 6. Post Herpetic Neuralgia Therapies Revenue Market Share by Application in 2020
Figure 7. Hospital Pharmacies Picture
Figure 8. Online Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Global Post Herpetic Neuralgia Therapies Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Post Herpetic Neuralgia Therapies Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Region (2016-2026)
Figure 13. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Region in 2020
Figure 14. North America Post Herpetic Neuralgia Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Post Herpetic Neuralgia Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Post Herpetic Neuralgia Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Post Herpetic Neuralgia Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Post Herpetic Neuralgia Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Post Herpetic Neuralgia Therapies Market Drivers
Figure 20. Post Herpetic Neuralgia Therapies Market Restraints
Figure 21. Post Herpetic Neuralgia Therapies Market Trends
Figure 22. Endo Pharmaceuticals Recent Developments and Future Plans
Figure 23. Depomed Recent Developments and Future Plans
Figure 24. Acorda Therapeutics Recent Developments and Future Plans
Figure 25. Pfizer Recent Developments and Future Plans
Figure 26. Mylan Recent Developments and Future Plans
Figure 27. Daiichi Sankyo Recent Developments and Future Plans
Figure 28. Teikoku Pharma Recent Developments and Future Plans
Figure 29. Global Post Herpetic Neuralgia Therapies Revenue Share by Players in 2020
Figure 30. Post Herpetic Neuralgia Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 31. Global Top 3 Players Post Herpetic Neuralgia Therapies Revenue Market Share in 2020
Figure 32. Global Top 10 Players Post Herpetic Neuralgia Therapies Revenue Market Share in 2020
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 34. Global Post Herpetic Neuralgia Therapies Revenue Share by Type in 2020
Figure 35. Global Post Herpetic Neuralgia Therapies Market Share Forecast by Type (2021-2026)
Figure 36. Global Post Herpetic Neuralgia Therapies Revenue Share by Application in 2020
Figure 37. Global Post Herpetic Neuralgia Therapies Market Share Forecast by Application (2021-2026)
Figure 38. North America Post Herpetic Neuralgia Therapies Sales Market Share by Type (2016-2026)
Figure 39. North America Post Herpetic Neuralgia Therapies Sales Market Share by Application (2016-2026)
Figure 40. North America Post Herpetic Neuralgia Therapies Revenue Market Share by Country (2016-2026)
Figure 41. United States Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Post Herpetic Neuralgia Therapies Sales Market Share by Type (2016-2026)
Figure 45. Europe Post Herpetic Neuralgia Therapies Sales Market Share by Application (2016-2026)
Figure 46. Europe Post Herpetic Neuralgia Therapies Revenue Market Share by Country (2016-2026)
Figure 47. Germany Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Post Herpetic Neuralgia Therapies Sales Market Share by Type (2016-2026)
Figure 53. Asia-Pacific Post Herpetic Neuralgia Therapies Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Post Herpetic Neuralgia Therapies Revenue Market Share by Region (2016-2026)
Figure 55. China Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South Korea Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Post Herpetic Neuralgia Therapies Sales Market Share by Type (2016-2026)
Figure 62. South America Post Herpetic Neuralgia Therapies Sales Market Share by Application (2016-2026)
Figure 63. South America Post Herpetic Neuralgia Therapies Revenue Market Share by Country (2016-2026)
Figure 64. Brazil Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Argentina Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Middle East and Africa Post Herpetic Neuralgia Therapies Sales Market Share by Type (2016-2026)
Figure 67. Middle East and Africa Post Herpetic Neuralgia Therapies Sales Market Share by Application (2016-2026)
Figure 68. Middle East and Africa Post Herpetic Neuralgia Therapies Revenue Market Share by Country (2016-2026)
Figure 69. Turkey Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Saudi Arabia Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. UAE Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source
世界の子宮がん治療・診断市場 2021：企業別、地域別、種類・用途別 The Uterine Cancer Therapies and Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…- 世界の自己幹細胞治療市場 2021：企業別、地域別、種類・用途別 The Autologous Stem Cell Based Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界の放射線皮膚炎治療市場 2021：企業別、地域別、種類・用途別 The Radiation Dermatitis Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界のがん治療用遺伝子治療市場 2021：企業別、地域別、種類・用途別 The Gene Therapies for Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界の静脈内免疫グロブリン療法市場 2021：企業別、地域別、種類・用途別 The Intravenous Immune Globulin Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…